Displaying 1 to 11 of 11 investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
ActivX Biosciences Inc Discoverer and developer of highly selective, best in class, small molecule drugs for major unmet medical needs. |
United States | N/A Active |
|||
Alder Biopharmaceuticals Inc Developer of antibody therapeutics. |
United States | N/A |
|||
Cell Biosciences Inc |
United States | N/A |
|||
Elevation Pharmaceuticals Inc |
United States | 1 Jan 2012 | Series B |
||
FoldRx Pharmaceuticals Inc |
United States | 1 Jun 2010 | N/A |
||
HTG Molecular Diagnostics Inc |
United States | N/A |
|||
Metabolex Inc Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. |
United States | 1 Nov 2009 | N/A |
||
Metabolex Inc Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. |
United States | 1 Apr 2007 | Series D |
||
Neomend Inc A biomedical device company, engages in the development and commercialization of surgical wound healing products |
United States | 1 Jan 2010 | Series D Active |
||
Otonomy Inc A biopharmaceutical company, engages in the development and commercialization of treatments for diseases of the inner and middle ear. |
United States | N/A |
|||
ProteinSimple ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. |
1 Jan 2006 | Series B |